PCN88 AN ECONOMIC EVALUATION OF RITUXIMAB VERSUS OTHER FIRST-LINE TREATMENTS FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN POLAND
Abstract
Authors
P Kawalec E Stawowczyk M Russel-Szymczyk M Szkultecka-Debek R Aultman E Carr E Lech-Maranda A Krawcewicz M Wach G Mazur